These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9218709)

  • 1. A partial agonist model used in the allosteric modulation of the NMDA receptor.
    Robichon R; Randall PK; Leslie SW
    Eur J Pharmacol; 1997 Jun; 328(2-3):255-63. PubMed ID: 9218709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
    Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
    Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]5,7-dichlorokynurenic acid recognizes two binding sites in rat cerebral cortex membranes.
    Mugnaini M; Antolini M; Corsi M; van Amsterdam FT
    J Recept Signal Transduct Res; 1998; 18(2-3):91-112. PubMed ID: 9651880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric modulation of [3H]CGP 39653 binding by glycine in rat brain.
    Mugnaini M; Giberti A; Ratti E; van Amsterdam FT
    J Neurochem; 1993 Oct; 61(4):1492-7. PubMed ID: 8104234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
    Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
    Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex allosteric modulation of the binding of the NMDA receptor antagonist [3H]CGP39653.
    Oblin A; Schoemaker H
    Eur J Pharmacol; 1994 Jan; 266(1):103-6. PubMed ID: 7907987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors.
    Danysz W; Fadda E; Wroblewski JT; Costa E
    Mol Pharmacol; 1989 Dec; 36(6):912-6. PubMed ID: 2574820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of a brain N-methyl-D-aspartate- and D, L-epsilon-2-amino-4-propyl-5-phosphono-3-pentanoic acid (CGP 39653)-binding protein.
    Kumar KN; Johnson PS; Chen X; Pal R; Ahmad M; Ragland T; Bigge C; Michaelis EK
    Biochem Biophys Res Commun; 1998 Dec; 253(2):463-9. PubMed ID: 9878559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GV 150526A, 7-Cl-kynurenic acid and HA 966 antagonize the glycine enhancement of N-methyl-D-aspartate-induced [3H]noradrenaline and [3H]dopamine release.
    Mennini T; Mancini L; Reggiani A; Trist D
    Eur J Pharmacol; 1997 Oct; 336(2-3):275-81. PubMed ID: 9384243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain.
    Sills MA; Fagg G; Pozza M; Angst C; Brundish DE; Hurt SD; Wilusz EJ; Williams M
    Eur J Pharmacol; 1991 Jan; 192(1):19-24. PubMed ID: 1674916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]5,7-dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites.
    Baron BM; Siegel BW; Slone AL; Harrison BL; Palfreyman MG; Hurt SD
    Eur J Pharmacol; 1991 Feb; 206(2):149-54. PubMed ID: 1829684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methyl-D-aspartate receptor binding is altered and seizure potential reduced in pregnant rats.
    Standley CA
    Brain Res; 1999 Oct; 844(1-2):10-9. PubMed ID: 10536256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation of [3H]-CGP39653 binding through the glycine site of the NMDA receptor: further studies in rat and human brain.
    Mugnaini M; Meoni P; Bunnemann B; Corsi M; Bowery NG
    Br J Pharmacol; 2001 Apr; 132(8):1883-97. PubMed ID: 11309261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
    Laurie DJ; Seeburg PH
    Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for heterogenous glycine domains but conserved multiple states of the excitatory amino acid recognition site of the NMDA receptor: regional binding studies with [3H]glycine and [3H]L-glutamate.
    O'Shea RD; Manallack DT; Conway EL; Mercer LD; Beart PM
    Exp Brain Res; 1991; 86(3):652-62. PubMed ID: 1684753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]CGP 39653 binding to the agonist site of the N-methyl-D-aspartate receptor is modulated by Mg2+ and polyamines independently of the arcaine-sensitive polyamine site.
    Reynolds IJ
    J Neurochem; 1994 Jan; 62(1):54-62. PubMed ID: 7903355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims.
    Nowak G; Ordway GA; Paul IA
    Brain Res; 1995 Mar; 675(1-2):157-64. PubMed ID: 7796124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin potentiation of [3H]CGP-39653 binding to rat brain membranes.
    Dumont M; Lemaire S
    Eur J Pharmacol; 1994 Dec; 271(1):241-4. PubMed ID: 7698209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regionally distinct stoichiometry for N-methyl-D-aspartate receptor domains in brain.
    Matsunaga T; Mukhin AG; London ED
    Neuroreport; 1996 Feb; 7(3):833-7. PubMed ID: 8733756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.